A randomized controlled trial of repetitive transcranial magnetic stimulation plus donepezil vs donepezil alone for mild to moderate cognitive impairment due to small vessel cerebrovascular disease.

Compared to donepezil hydrochloride alone, the combination of repetitive transcranial magnetic stimulation (rTMS) and donepezil hydrochloride has a significantly greater effect on enhancing cognitive function among individuals experiencing mild-to-moderate cognitive impairment resulting from SVCVD.